Douglas Swirsky - Jun 30, 2021 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for Douglas J. Swirsky
Stock symbol
CLRB
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 04:04 PM
Next filing
Sep 14, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +117K $0.00 117K Jun 30, 2021 Common Stock 117K $1.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest on the first anniversary of the date of grant.